Home > Healthcare > Medical Devices > Diagnostic Devices > Hemato Oncology Testing Market

Hemato Oncology Testing Market Share

  • Report ID: GMI10902
  • Published Date: Aug 2024
  • Report Format: PDF

Hemato Oncology Testing Market Share

The market is characterized by intense competition among key players aiming to expand their market presence. Leading companies are focusing on strategic initiatives such as mergers, acquisitions, and partnerships to strengthen their market position. These efforts are aimed at enhancing their product and service offerings, expanding their geographic reach, and investing in advanced technologies. The market also witnesses the entry of new players, intensifying the competitive landscape further.
 

Hemato Oncology Testing Market Companies

Prominent players operating in the hemato oncology testing industry are as mentioned below:

  • Abbott Laboratories
  • ARUP Laboratories
  • Bio-Rad Laboratories Inc.
  • Danaher Corporation (Integrated DNA Technologies, Inc.)
  • Entrogen Inc.
  • F. Hoffmann-La Roche Ltd.
  • Illumina, Inc.
  • Invivoscribe, Inc.
  • Invitae Corporation (Archerdx, Inc.)
  • QIAGEN N.V.
  • Thermo Fisher Scientific, Inc.
  • Vela Diagnostics
Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global hemato oncology testing market was valued at USD 3.2 billion in 2023 and will grow at 14.2% CAGR during 2024-2032, fueled by the rising prevalence of hematological malignancies.

The kits & reagents segment in the market recorded USD 1.7 billion in 2023 and will expand through 2032, driven by rising demand for personalized medicine, which tailors treatments to a patient's genetic and molecular profile.

North America hemato oncology testing market recorded 45.6% share in 2023 and will grow rapidly through 2032, driven by the rising rates of hematological cancers, including leukemia, lymphoma, and multiple myeloma,

Abbott Laboratories, ARUP Laboratories, Bio-Rad Laboratories Inc, Danaher Corporation (Integrated DNA Technologies, Inc.), Entrogen Inc, F. Hoffmann-La Roche Ltd, and Illumina, Inc among others.

Hemato Oncology Testing Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 12
  • Tables & Figures: 405
  • Countries covered: 21
  • Pages: 232
 Download Free Sample